Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-13 to 2024-03-26
Current total value of award: $476414.19
Description: 8510500535!ADENOVIRUS TYPE 4 A